879 Reversal of lactate and PD-1-mediated macrophage immunosuppression controls growth of PTEN/p53-deficient prostate cancer

Clinical cancer research : an official journal of the American Association for Cancer Research(2022)

Cited 14|Views33
No score
Abstract
Immunometabolic strategies that reverse lactate and PD-1-mediated TAM immunosuppression, in combination with ADT, warrant further investigation in PTEN-deficient mCRPC patients.
More
Translated text
Key words
macrophage immunosuppression controls growth,prostate cancer,lactate
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined